Pharmaceuticals - Indian - Formulations
Peer Comparison
Company | LTP | Market Cap (in ₹ Cr) |
---|---|---|
Adline Chem Lab Ltd | ₹25.49 | ₹14.91 |
Sun Pharmaceuticals Industries Ltd | ₹1,803.25 | ₹4,32,660.08 |
Divis Laboratories Ltd | ₹5,808.20 | ₹1,54,189.46 |
Cipla Ltd | ₹1,601.25 | ₹1,29,316.22 |
Mankind Pharma Ltd | ₹2,714.40 | ₹1,08,750.85 |
Torrent Pharmaceuticals Ltd | ₹3,186.35 | ₹1,07,835.72 |
29 Oct 2024
23 Oct 2024
28 Aug 2024
17 Aug 2024
09 Jul 2024
Financials
Profit and Loss
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 0.03 | 1 | 0.92 | 6.33 | 6.61 |
Total Expenses | 0.18 | 0.88 | 1.39 | 7.61 | 10.37 |
Profit Before Tax | -0.15 | -4.23 | 0.67 | -1.28 | -3.51 |
Profit After Tax | -0.15 | -4.23 | 0.72 | -1.28 | -3.76 |
Operating Profit after Depreciation | -0.15 | 0.11 | -0.46 | -1.25 | -3.73 |
Balance Sheet
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | - | - | 4.43 | 3.64 | 4.78 |
Total Non Current Assets | - | - | 4.44 | 3.65 | 4.82 |
Total Current Assets | 0.04 | 0.06 | 0.43 | 1.98 | 2.77 |
TOTAL ASSETS | 0.04 | 0.06 | 4.87 | 5.63 | 7.58 |
Total Shareholder's Fund | -1.71 | -1.57 | 2.65 | 1.93 | 3.21 |
Cash Flow
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -0.02 | 0.01 | 0.21 | -0.29 | -11.34 |
Net Cash used in Investing Activities | - | - | - | 0.12 | 11.24 |
Net Cash used in Financing Activities | - | - | -0.01 | -0.03 | -0.02 |
Corporate Actions